Merkliste 
 1 Ergebnisse 
 
1

CAMRESBRT: Randomized Phase II Trial of Camrelizumab with S..:

Lei, Q. ; Wang, Y. ; Sui, J....
International Journal of Radiation Oncology*Biology*Physics.  114 (2022)  3 - p. e282 , 2022